secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2026-08-07T22:49:53+00:00
Accession:  0001193125-26-340664
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences receives Nasdaq delisting notice for bid price below $1.00
------------------------------------------------------------------------------

- Nasdaq notice on Aug 4, 2026: RKDA failed minimum bid price ($1.00) for 30 consecutive business days (Jun 22–Aug 3).
- 180-day cure period until Feb 1, 2027; must close at $1.00+ for 10 consecutive business days to regain compliance.
- Company may consider reverse stock split to cure deficiency; no immediate impact on listing or trading.
- If not cured by Feb 1, 2027, may qualify for additional 180-day period if other listing standards are met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526340664/0001193125-26-340664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312526340664/rkda-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-340664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer